![]() |
JOURNAL TOOLS |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |

YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS ESOPHAGEAL CANCER
Minerva Chirurgica 2002 December;57(6):837-45
Copyright © 2002 EDIZIONI MINERVA MEDICA
language: English
Role of FDG-PET scan in staging of cancer of the esophagus and gastroesophageal junction
Lerut T., Flamen P.
Background. FDG-PET scan has generated in recent years an increasing interest in staging and assessment of response to treatment in cancer patients.
Methods. From the available literature and own data it appears that FDG-PET scan significantly improves detection of haematogenous and distant lymphatic metastasis in carcinoma of the oesophagus and gastro-oesophageal junction (GEJ). Especially diagnostic specificity of lymph node involvement is greatly improved with FDG-PET scan. FDG-PET scan also allows a highly sensitive diagnosis of recurrent disease through its capacity of whole-body staging. In assessing response of induction (chemo ± radiotherapy) in locally advanced disease FDG-PET scan appears to be of high value in predicting response.
Results. Moreover, there seems to be a strong correlation between FDG-PET scan response and survival.
Conclusions. It can be concluded that despite the cost, FDG-PET scan should have a place in the algorithm of initial staging, staging of recurrent disease and assessment of response to treatment in cancer of the oesophagus and GE junction.